Atovacuona‐proguanil para el tratamiento del paludismo no complicado
Información
- DOI:
- https://doi.org/10.1002/14651858.CD004529.pub2Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 19 octubre 2005see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Enfermedades infecciosas
- Clasificada:
-
- Pendiente de actualización
Authors currently updating
The update is due to be published in 2019.Evaluada: 22 March 2019
- Pendiente de actualización
- Copyright:
-
- Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Alex Osei‐Akoto and Shirley Owusu‐Ofori drafted the review, and Lois Orton commented on the review. All three authors completed the review.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
Department for International Development, UK.
Declarations of interest
None known.
Acknowledgements
The protocol for this Cochrane Review was developed during the Mentorship Programme organized by the Cochrane Infectious Diseases Group, July 2002. The UK Department for International Development (DFID) supports this Programme through the Effective Health Care Alliance Programme (EHCAP) at the Liverpool School of Tropical Medicine. Alex Osei‐Akoto and Shirley Owusu‐Ofori received funding from DFID through EHCAP to travel to the Liverpool School of Tropical Medicine to complete the review. Harriet G MacLehose (Assistant Editor, Cochrane Infectious Disease Group) resolved disagreements between authors about trial selection and data extraction.
This document is an output from a project funded by DFID for the benefit of developing countries. The views expressed are not necessarily those of DFID.
Version history
| Published | Title | Stage | Authors | Version |
| 2021 Jan 18 | Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria | Review | Andrew Blanshard, Paul Hine | |
| 2005 Oct 19 | Atovaquone‐proguanil for treating uncomplicated malaria | Review | Alex Osei‐Akoto, Lois C Orton, Shirley Owusu‐Ofori | |
| 2003 Oct 20 | Atovaquone‐proguanil for treating uncomplicated malaria | Protocol | A Osei‐Akoto, Lois C Orton, Shirley PO Owusu‐Ofori, Alex YA Osei | |
Differences between protocol and review
Issue 4, 2005 (first review version): In line with the Cochrane Infectious Diseases Group (CIDG) new guidelines we no longer include quasi‐randomized controlled trials, modified the primary outcome measure (protocol: "Parasitaemia by days 14 and 28"), removed the secondary outcome measure "Parasitaemia by day 28, adjusted to exclude new infections using PCR", added "Treatment failure* on or by day 14" as a secondary outcome measure, and modified the method to assess blinding in trials.
